Pharmaceutical research allows scientists to work as a team on projects that develop cures for different neurological problems. Bill Martin discusses why working in industry aligned so well with his career goals and allows him to work on many aspects of each of the projects he contributes to.
Access to the full article is available to SfN members.
Neuronline is a benefit of SfN membership. Renew your membership now to make sure you don’t lose access.
Speaker
Bill Martin, PhD
Bill Martin leads the neuroscience therapeutic area of Janssen Research & Development, LLC in discovering and developing important new therapies for people living with brain disorders. Prior to joining BlackThorn, Martin worked at Theravance Biopharma, where his responsibilities ranged from drug discovery and development, to research portfolio planning and business development. He is the chair of SfN’s Government and Public Affairs Committee. Martin graduated from Swarthmore College and earned his PhD from Brown University. He conducted postdoctoral research at the Keck Center for Integrative Neuroscience at the University of California, San Francisco.
0 of 5 articles left
Login
or
Become a Member
to unlock content